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Abstract
CD4+ T cells -- often referred to as T-helper cells -- play a central role in immune defense and
pathogenesis. Virus infections and vaccines stimulate and expand populations of antigen-specific
CD4+ T cells in mice and in man. These virus-specific CD4+ T cells are extremely important in
antiviral protection: deficiencies in CD4+ T cells are associated with virus reactivation,
generalized susceptibility to opportunistic infections, and poor vaccine efficacy. As described
below, CD4+ T cells influence effector and memory CD8+ T cell responses, humoral immunity,
and the antimicrobial activity of macrophages and are involved in recruiting cells to sites of
infection. This review summarizes a few key points about the dynamics of the CD4+ T cell
response to virus infection, the positive role of pro-inflammatory cytokines in the differentiation
of virus-specific CD4+ T cells, and new areas of investigation to improve vaccines against virus
infection.
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Introduction
Viruses and the immune system are linked: viruses infect and replicate in an environment
where cells are devoted to destroying the infection, so viruses have evolved mechanisms to
elude the immune response; conversely, viruses have impacted the survival of their hosts, so
the genomes of survivors are imprinted by past battles. Viruses and the immune system
change in real time during an infection with detectable heritable changes in the viral genome
and the selective expansion and differentiation of T cells and B cells with epigenetic
changes that carry on for the life of the animal. The study of how the immune system copes
with virus infection is key to understanding virus replication strategies and their overall
structure, why certain populations of cells are targeted for infection, and the selection of
virus mutants with growth advantage. Likewise, one can decipher how the immune system
functions by studying how viruses evolve to survive and propagate in hosts.
CD4+ T cells impact antiviral immunity at multiple stages of the immune response. CD4+ T
cells influence antiviral cellular and humoral immunity and play a direct role in suppressing
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virus infection (Figure 1). As discussed below, CD4+ T cells enhance early expansion of
virus-specific primary CTL, their subsequent differentiation into memory cells, guide their
localization to sites of infection, and drive secondary expansion of memory CD8+ T cells
during re-infection. CD4+ T cells are critical for the processes that lead to long-term
humoral immunity, which is the basis of protection for many infections and vaccines. People
with deficiencies in CD4+ T cell responses or who have mutations in the molecules involved
in CD4-B cell interactions show severe defects in cellular and humoral immunity and suffer
from recurrent opportunistic infections. Antiviral CD4+ T cells may interact directly with
eosinophils and impact their recruitment and function in lung tissues, potentially
contributing to the pathogenesis seen after some lung infections. Thus, virus-specific CD4+
T cells form the nexus between immunologic protection and immune-mediated pathogenesis
following infection, so a deep understanding of their induction, regulation, and function is
needed to develop safe and effective vaccines against ongoing viral threats. A major point in
this review is that CD4+ T cell differentiation and activity is controlled by where they
reside.
The T cell response following virus infection consists of several stages (Figure 2). Innate
inflammatory processes begin immediately after infection and are largely driven by various
pattern recognition receptors, including Toll-Like Receptors (TLR) that recognize viral
material at the cell surface or within the endocytic compartment, and RIG-I-like receptors
(RLR) and nucleotide-binding domain-leucine-rich repeat-containing molecules (NLR) that
recognize viral material in the cytoplasm. These signals induce type 1 interferon production
and other pro-inflammatory cytokines; a cascade of signaling events occurs in cells
anywhere near the source of IFN. Interferon stimulated cells are induced to express new
proteins that have antiviral activities, including ISG15, ISG20, RNAse-L, protein kinase R
(PKR), 2′,5′oligoadenylate synthetases, Mx1, TRIM5α, and others (Borrow, Martinez-
Sobrido, and de La Torre, 2010;Wilkins and Gale, 2010). The effect of IFN can vary by cell
type. Besides direct antiviral effects, IFN transiently retains cells in lymphoid tissue by
stimulating CD69 expression, which blocks the activity of sphingosine 1-phosphate
receptor-1 (Shiow et al., 2006). IFN acts to enhance MHC presentation of antigens to T cells
and modifies the proteolytic machinery involved in producing the peptides that will be
recognized by T cells. IFNs stimulate APCs to express costimulatory molecules, potentiating
the adaptive T cell response. During this early time, NK cells become activated and release
interferon-gamma. The rapid detection of virus material and production of IFNs serves to
diminish virus replication and alert the immune system to infection. Within a few hours after
infection, viral antigen is presented to T cells and a few days later, there is an explosive
expansion of antiviral T cells (Whitmire, Benning, and Whitton, 2006;Whitmire, Eam, and
Whitton, 2008). It starts from a minute population of cells that begin dividing at incredibly
fast rates with the population doubling at a rate on the order of once per 4– 5 hours, and the
responding cells increase in number exponentially during this time (Whitmire, Benning, and
Whitton, 2006). Impressively, as the cells accumulate, they also differentiate into different
lineages and transition into memory cells, carryout their direct antiviral functions, travel
throughout the body, and assist other wings of the immune system (Whitmire, Benning, and
Whitton, 2006). These events unfold in an inflammatory environment that guides T cell
differentiation and is in turn impacted by their presence. The outcome of this complex
network of interactions is initially an expanded population of short-lived virus-reactive T
cells, some of which further differentiate and transition into quiescent memory cells, which
confer expedited immunity over extended periods of time. A key point is that innate and
adaptive immunity are linked: early inflammatory pathways have an immediate impact in
limiting infection and a long-term impact on T cell memory, influencing the kind and
number of memory cell that survives and the kind of recall response that develops upon re-
infection.
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The T cell response following virus infection typically consists of 2 major populations of
cells: virus-specific CD8+ T cells and CD4+ T cells
Antiviral CD8+ T cells and CD4+ T cell responses begin from a small number of naïve
precursor cells that expand in a non-linear way with roughly similar kinetics of induction
and cell-division rate (Whitmire, Benning, and Whitton, 2006; Whitmire, Eam, and Whitton,
2008). There are a number of differences between CD8+ T cells and CD4+ T cells, which
should be considered in order to understand why and how viruses avoid them.
Virus-specific CD8+ T cells and CD4+ T cells recognize different aspects of infection and
carryout distinct functions. CD4+ T cells recognize viral antigen that is presented by MHCII
molecules on a limited number of cells: dendritic cells (DC), B cells, and monocytes/
macrophages. CD4+ T cells “see” fragments of extracellular material that professional
antigen presenting cells (APC) have taken up, degraded, and presented in the context of
MHCII. DC efficiently take-up antigen in the periphery, then travel to the draining lymph
nodes, where they process and present antigen to T cells. The separation between
scavenging for foreign material and the presentation of that material at different sites is seen
for inert antigens, but may or may not hold following live virus infections where there is
active recruitment of activated APCs to the site of infection. As discussed below, CD4+ T
cells can engage these cells out in peripheral sites and impact their behavior or localization.
The extracellular material can include viral particles, viral proteins, and viral debris from
necrotic cells. In contrast to CD4+ T cells, CD8+ T cells recognize MHC1 molecules that
are loaded with peptides derived from intracellular proteins; these proteins are ubiquitinated
and degraded by the proteasome or immunoproteasome into peptides that are shuttled into
the secretory pathway, where they are loaded onto MHC1 molecules. The epitopes that are
presented on MHC1 molecules are largely derived from viral protein that has entered the
cytosol as a result of infection (fusion) or from proteins arising from the de novo synthesis
of viral protein from viral nucleic acid sequences. CD8+ T cells can be stimulated by
extracellular protein through a process termed “cross-presentation”, but the protective value
of this presentation, and the extent to which cross-presentation happens during the course of
a natural infection is not clear and could be somewhat less efficient compared with
endogenous “classical” pathways of antigen presentation; a recent study of vaccinia virus
infection found that direct presentation, and not cross-presentation, plays the major role in
the induction of antiviral CD8+ T cells (Xu et al., 2010). There are several recent reviews of
cross-presentation (Bevan, 2006; Blanchard and Shastri, 2010; Rock, Farfan-Arribas, and
Shen, 2010; Yewdell, 2010; Yewdell and Haeryfar, 2005).
CD4+ T cells can be induced by cells that are not actually infected and recognize antigen
from non-replicating virus material, so they can be far more sensitive to foreign antigen than
CD8+ T cells. For example, non-replicating or inactivated vaccines composed of viral
proteins or bacterial toxins induce CD4+ T cell responses but negligible CD8+ T cell
responses. Many viruses effectively inhibit antigen-presentation to CD8+ T cells, but such
blockade does not affect CD4+ T cells, since non-infected cells still efficiently take up and
present antigen. An example of this effect is seen following Coxsackie virus infection of
mice; certain viral proteins (2B, 2BC, 3A) prevent the surface expression of MHC1 (Cornell
et al., 2006; Cornell et al., 2007). Minimal to no detectable CD8 response is induced in these
mice, even when using extremely sensitive techniques; in contrast, CVB3-specific CD4+ T
cells are stimulated and readily measured (Kemball et al., 2009; Kemball, Harkins, and
Whitton, 2008). Other viruses, such as myxoma virus (Zuniga et al., 1999), adenovirus
(Blair and Blair-Zajdel, 2004; Windheim, Hilgendorf, and Burgert, 2004), HSV (Ahn et al.,
1996; Barcy and Corey, 2001; Neumann, Eis-Hubinger, and Koch, 2003; Orr et al., 2005;
Sievers et al., 2002; Temme et al., 2010), varicella-zoster virus (Eisfeld et al., 2007),
MCMV (del Val et al., 1992; Heise, Connick, and Virgin, 1998; Lemmermann et al.), and
HCMV (Jackson, Mason, and Wills, 2010), also have elaborate mechanisms to prevent
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MHC antigen presentation, thus reducing their visibility to the immune system. It is
intrinsically difficult for viruses to dodge CD4+ T cell responses, but several major
mechanisms have been identified, including the production of viral homologs of IL-10
(EBV, MCMV) (Kanai et al., 2007; Knappe et al., 2000; Kotenko et al., 2000) to generally
suppress MHC expression, targeting DC for depletion by CD8+ T cells (Zuniga et al., 2008),
and down-regulating MHCII expression on infected cells (Hegde et al., 2002; Lewandowski,
Lo, and Bloom, 1993).
Another key difference between virus-specific CD8+ T cells and CD4+ T cells is the
efficiency with which they kill target cells: this is done expeditiously by antigen-
experienced CD8+ T cells, whereas such killing by CD4+ T cells is sluggish. This can be
demonstrated using an “in vivo CTL assay”. In this assay, target cells are loaded with
specific or irrelevant peptides and then differentially labeled with a dye (CFSE) and
intravenously transferred into the same host; after a short period of time, flow cytometry is
used to compare the relative loss of the specific peptide-coated cells compared to the control
target cells. When target cells are loaded with an LCMV peptide that binds MHCI and is
recognized by immunodominant LCMV-specific CD8+ T cells, they are completely
eliminated within minutes upon transfer into an LCMV-immune mouse. By comparison,
only a small fraction of GP61–80-loaded target cells are killed in these mice over a time span
of one day. Thus cytolytic CD4+ T cells emerge after infection (Jellison, Kim, and Welsh,
2005), but their protective role based on direct killing of target cells after infection pales in
comparison with virus-specific CD8+ T cells that kill within minutes (Yates et al., 2007).
This is underscored by the inability of CD8-deficient mice to resolve LCMV infection
despite the presence of large numbers of virus-specific CD4+ T cells. The mechanisms of
killing are also very different: CD8+ CTL rely upon preformed perforin and granzyme
molecules to poke holes into the target cells; CD4+ T cells utilize FAS-L and TRAIL to
induce a caspase-dependent apoptosis. The dichotomy in rapid killing ability makes sense
given that cytolytic cells are restricted to targets that are actually infected as opposed to
nearby antigen presenting cells that have taken up antigen and are involved in alerting the
immune system to infection. Such restricted killing may be beneficial by preserving APC
whose depletion would cause generalized immune incompetence. An example of the
detrimental effects of APC loss are seen following infection of mice with LCMV variants
that selectively infect DC; the resulting CTL response eliminates these cells and the mice
become susceptible to other infections (Sevilla et al., 2000; Sevilla et al., 2003; Zuniga et al.,
2008). Similar pathogenesis may occur in people exposed to influenza, who then acquire
lethal bacterial infections. Virus-specific CD4+ and CD8+ T cells share the ability to
directly suppress virus replication by bathing target cells in IFNγ, but CD4+ T cells
accomplish this without the collateral damage caused by perforin-dependent cell killing.
CD4+ T cells help CD8+ T cell-dependent antiviral defenses
For many virus infections CD4+ T cells are needed to drive the initial expansion of virus-
specific CD8+ T cells (Williams and Bevan, 2007). In the absence of CD4+ T cells there is
minimal expansion of CD8+ T cells and deficient cellular immunity. Virus-specific CD4+ T
cells engage DCs that are shared with reactive CD8+ T cells; the CD4+ T cells stimulate the
APCs to express costimulatory molecules and to increase the presentation of viral antigen so
that the APCs better stimulate CD8+ T cells. CD4+ T cells are efficient producers of IL-2,
which is a growth factor for CD8+ T cells and encourages improved cell-division and cell
survival. It is plausible that virus-specific CD4+ T cell production of IL-2 (and IFNγ, see
below) acts on nearby virus-specific CD8+ T cells. Such interactions might occur when both
cells are adjacent to a virus infected APC.
Many virus infections grow to high titer in vivo and, due to efficient MHCI presentation,
readily stimulate virus-specific CD8+ T cells. Virus-specific CD4+ T cells often are not
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needed for the initial expansion of CD8+ T cells in these models. However, CD4+ T cells
affect the subsequent ability of memory CD8+ T cells to undergo vigorous secondary
responses upon re-challenge with infection (Hamilton et al., 2006; Janssen et al., 2003;
Shedlock and Shen, 2003; Sun and Bevan, 2003; Sun, Williams, and Bevan, 2004).
Evidence indicates that early CD4− dependent signals leave a lasting effect on memory cell
formation; help-less CD8 T cells expand poorly compared to those that differentiate in the
presence of CD4+ T cells. Other evidence implicates memory CD4+ T cell effects during
the actual recall response itself (Agnellini et al., 2008). In this case, CD4+ T cells deliver
signals – and it is not clear what they are – that further the ability of responding memory
CD8+ T cells to accumulate in number (Sun, Williams, and Bevan, 2004). The simultaneous
activation of memory CD4+ T cells and memory CD8+ T cells results in a more protective
CTL response compared to the activation of CD8+ T cells alone.
Antiviral T cells circulate widely after infection (Marshall et al., 2001; Masopust et al.,
2001; Whitmire, Benning, and Whitton, 2006). In several model systems, antiviral CD4+ T
cells are needed to recruit CD8+ T cells and other cell types to peripheral sites of infection.
For example, CD4+ T cells recruit mouse hepatitis virus-specific CD8+ T cells into the CNS
(Stohlman et al., 1998). CD4+ T cells recruit influenza-specific CD8+ T cells into the lung
(Teijaro et al., 2010). HSV2-specific CD4+ T cells enhance CD8+ T cell movement to
HSV2 infected tissues, and the effect is dependent upon IFNγ production by the CD4+ T
cells and the local induction of CXCR3 that allows circulating CD8+ T cells to enter the
tissue (Nakanishi et al., 2009). Perhaps the local production of IFNαβ caused by infection
results in an influx of cells, including those with antigen presenting functions and CD4+ T
cells. Once there, CD4+ T cells direct other responses locally and guide other cell types into
the infected tissue (Lane et al., 2000).
Virus-specific CD4+ T cells sustain antiviral CD8+ T cell responses during protracted
infections (Khanolkar, Fuller, and Zajac, 2004; Kumaraguru, Banerjee, and Rouse, 2005;
Wherry et al., 2007; Zajac et al., 1998a). For example, variants of LCMV will grow to high
titer and target new populations of cells and disseminate throughout the body of the mouse.
The CD8+ T cell response against these variants is strained and eventually virus-specific
CD8+ T cells either undergo apoptosis or become dysfunctional (exhausted), losing their
ability to proliferate and produce cytokines when exposed to their cognate antigen.
Eventually, wildtype mice reduce the viral load to levels at or below the detection limits of
plaque assay in most tissues but not mice that are depleted of CD4+ T cells (Battegay et al.,
1994; Leist, Kohler, and Zinkernagel, 1989; Matloubian, Concepcion, and Ahmed, 1994).
Transient depletion of CD4+ T cells is sufficient to prevent long-term control of these
variants. In wildtype mice, functional cytolytic CD8+ T cells can be recovered once the
infection is controlled, but in CD4-deficient mice, functional CD8+ T cells are not
recovered. Dysfunctional CD8+ T cells can be rescued by the adoptive transfer of functional
CD4+ T cells (Homann et al., 1998; Kumaraguru, Banerjee, and Rouse, 2005). The
mechanism by which CD4+ T cells rescue virus-specific CD8+ T cells is elusive; it could be
related to the release of copious amounts of IL-2 that acts on CD8+ T cells, the ability of
CD4+ T cells to stimulate APC activity or survival that indirectly sustains CD8+ T cells, or
possibly modulation of inhibitory receptor-ligand interactions between CD8+ T cells and
APCs. Virus-specific CD4+ T cell production of IL-21 sustains antiviral CD8+ T cells
during persistent virus infection (Elsaesser, Sauer, and Brooks, 2009; Frohlich et al., 2009;
Melief and Schoenberger, 2010; Yi, Du, and Zajac, 2009; Yi, Ingram, and Zajac, 2010).
CD4+ T cells may also protect APCs from CTL-mediated killing (Mueller et al., 2006), thus
preserving their immune-stimulatory functions.
Whitmire Page 5













Big responses from small numbers
The T cell Receptor consists of several subunits, and the regions involved in binding peptide
and MHC complexes are highly variable and lead to a diverse array of pro-T cells that travel
from the bone marrow to the thymus; a subset of the cells go on to differentiate into single
positive CD4+ or CD8+ T cells that populate the peripheral lymphoid organs. Based on the
number of domains, their random juxtaposition and additional sequences that are added at
the joining sites, the theoretical variety of unique TCRs is enormous and far greater than the
actual number of cells in a mouse. Until recently, the frequency of any given antigen-
specific T cell in the naïve pool was unknown, but it was estimated by CDR3-length
measurements of different classes of TCR molecules that there are approximately 2×106
distinct T cell precursor pools, each containing an average of 10 cells (Casrouge et al.,
2000). This estimate was largely borne-out by direct measurements of antigen-specific cells
using either functional methods or tetramer-enrichment techniques. For example, in an
uninfected wildtype (B6) mouse, there are approximately 100 CD4+ T cells with the
potential to respond to an immuno-dominant I-Ab-restricted epitope of LCMV (GP61–80)
(MacLeod et al., 2008; Whitmire, Benning, and Whitton, 2006). A similar frequency for an
immuno-dominant LCMV-specific CD8+ T cell population (Blattman et al., 2002) indicates
that there is overlap in the frequencies of precursors between immuno-dominant CD4+ and
CD8+ T cells. The frequency for other epitope-specific T cell precursors ranges from ~10–
1,000 per mouse (Hataye et al., 2006; Moon et al., 2007; Obar, Khanna, and Lefrancois,
2008). There is a trend where the initial naïve precursor frequency correlates with the
subsequent immunodominance hierarchy that is seen following infection, but this pattern
does not always hold.
The induction phase of the response commences immediately upon infection and involves
viral antigen along with inflammatory signals and costimulatory signals. Within a few hours
after infection, viral antigen is presented to T cells at sufficient levels to stimulate antigen-
experienced cells to make cytokine (Whitmire, Eam, and Whitton, 2008). This can be shown
experimentally by re-challenging immune mice, which contain large numbers of memory T
cells, and then directly injecting BFA soon afterwards. The BFA acts to prevent T cell
secretion of IFNγ, so reactive cells accumulate this cytokine following antigen exposure in
vivo. The cells are isolated and immediately stained for intracellular IFNγ without further
ex-vivo manipulation. A large fraction of virus-specific CD4+ T cells will express IFNγ 6–
12 hours after infection, indicating that those cells recognized their cognate antigen in vivo.
The actual speed with which antigen is presented may be much faster and on a timescale of
minutes. From the standpoint of virus infection, it is important to have an adaptive response
that matches the rate at which viruses replicate and spread. These events can happen quickly
(such as LCMV replication and spread in mice) and the T cell response occurs quickly; other
infections are slow and the resulting T cell response dithers. For example, the T cell
responses against mycobacteria peak one month after infection; the T cell responses against
the hepatotropic viruses HAV and HCV only emerge 4– 6 weeks after infection. It is unclear
why the kinetics vary so dramatically – different viruses and other pathogens influence the
kind of milieu that forms during these critical stages of the T cell response, and this may
explain the variation in kinetics, quality and magnitude of subsequent memory T cells. It is
also possible that some viruses have evolved mechanisms to delay the kinetics to facilitate
virus survival and spread. For example, the liver environment suppresses immune responses,
which may explain why viruses targeting that location induce small and delayed immune
responses.
Despite the initial presence of LCMV antigen, virus-specific naïve and memory T cells
undergo cell division after a delay of up to 3 days, followed by an explosive transition into
extremely rapid cell division and accumulation (Whitmire, Eam, and Whitton, 2008). The
initiation of the response is governed, at least in part, by the inflammatory environment as
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opposed to intrinsic limits governing the ability of T cells to transform from quiescent cells
to ones that are fully capable of dividing. T cells that are placed within an inflamed
environment (i.e. a pre-infected mouse) are able to begin dividing without much delay (2
days as opposed to 3– 4 days), which implies that certain signals beyond antigen, are
involved in initiating the rapid response. These signals could include the induction of
positive regulators or the elimination of negative regulators or Treg cells.
As the response develops, populations of cells are differentially impacted by various
selective forces – including antigen abundance, TCR-peptide/MHC affinity, and cytokines –
that determine the cells that preferentially grow out in number and contribute to T cell
differentiation and survival into the memory phase. The magnitude of the CD4 response is
largely governed by the amount and duration of antigen (Obst et al., 2005; Ravkov and
Williams, 2009). The CD4 response truncates when infection is artificially terminated, such
as by treating recombinant-Listeria monocytogenes-infected mice with antibiotics. Similar
findings were seen following recall responses. These analyses were done in the context of
LM-driven T cell responses; whether similar correlations hold for virus infection remains to
be shown. Analogous experiments using ribavirin in virus infected mice should be done to
evaluate whether antiviral CD4+ T cell responses are also highly dependent on antigen-dose
and duration.
Remarkably, much of the virus-specific CD4+ T cell accumulation occurs within a few days,
implying cell-division rates on the order of one population doubling every 4–5 hours, but
possibly faster if some of the daughter cells undergo apoptosis during the response. Given
the speed with which viruses replicate, it is important to have an adaptive immune system
that can keep up; on the other hand, a robust autoreactive response or one that is otherwise
misdirected could lead to catastrophic immune-mediated pathology. Therefore, the response
is heavily governed, but the details of how this occurs are obscure.
Virus infections stimulate distinct lineages of CD4+ T cells that serve unique functions
As antigen-specific CD4+ T cells respond to infection, they differentiate into lineages and
produce characteristic sets of cytokines that impact how they influence other components of
the immune response. They also express certain chemokine receptors that govern whether
they travel to peripheral sites, localize within lymphoid organs in T cell zones, or localize
near B cell zones. The overall kinetics of the CD4+ T cell response and their survival/
maintenance into to the memory phase has been studied in models that induce
predominantly a Th1-type response. Antiviral Th1 cells are commonly found after live virus
infections, because target cells typically produce IFNαβ, and DC and NK cells produce
IL-12, IL-18 and IFNγ that stimulate cells to differentiate into the Th1 path. Th1 cells are
located in lymphoid organs but also travel to peripheral sites. They express IFNγ, which acts
on target cells to directly suppress virus replication and augments antigen presentation by
DC, B cells, and macrophages. Th1 cells also make IL-2 to support the expansion of other
responding T cells. Th1 cells in the periphery produce IFN that modulates chemokine
gradients and causes macrophages and CD8+ T cells to be recruited to sites of infection.
Virus-specific TFH cells emerge after infection (Johnston et al., 2009; Yusuf et al., 2010).
TFH cells preferentially localize to the B cell boundaries within lymph nodes rather than
circulate to peripheral sites (McHeyzer-Williams and McHeyzer-Williams, 2004). Given
their proximal location to B cell areas, it is thought that TFH cells are directly involved in B
cell differentiation, including the germinal center response and memory B cell formation
(McHeyzer-Williams et al., 2009). These CD4+ T cells express CD40L and SAP that are
vital for stimulating virus-specific B cells to further differentiate into MBC or plasma cells
(Crotty et al., 2003; McHeyzer-Williams and McHeyzer-Williams, 2004). Virus-specific
TFH cells express IL-4 (a B cell growth factor and differentiation factor), IFNγ (also a B cell
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differentiation factor), and CD40L. The ability of TFH cells to simultaneously make IFNγ
and IL-4 may explain why IgG1 and IgG2a antibodies are often found together after
infection. Many interesting questions remain about this population of cells: are they short-
lived or long-lived; do they form memory; how are they related to other populations of
virus-specific CD4+ T cells.
The patterns and behaviors of the other lineages may be similar or different to Th1 cells, so
comparable analyses in other infection models would be useful, as they would provide
insights about adjuvant design and overall regulation of immunity and immune-mediated
pathogenesis. For example, virus-specific Th2 cells are found after some infections. RSV in
particular induces a Th2 response that is associated with pathogenesis and an excessive
influx of eosinophils into the lung. Virus-specific Th17, Th21, Th9, and TReg emerge after
virus infections, but much remains to be learned about their regulation, function, and
longevity. Virus-specific cytotoxic CD4+ T cells are found during some virus infections
(HCMV, MCMV, others) (Appay et al., 2002). Cytotoxic CD4+ T cells express IFNγ and
granzyme and FasL could be regarded as a subset of Th1 cells, but it is possible that they are
a unique lineage, and their relationship to other cells is not clear. These cells hold potential
for therapeutic applications: when primed and expanded artificially, they can be adoptively
transferred into people with certain tumors to kill transformed cells.
It is important to consider that live virus infections create unique milieus that result in
complex mixtures of responses, so in an individual there can be a mixture of CD4+ T cells
from different lineages (Marzo et al., 2002; Roman et al., 2002). CD4+ T cells tend to fall
neatly into distinct lineages, but recent data suggest there is pliability: Th2 cells can be “re-
programmed” into Th1 when exposed to the interferons that are expressed during virus
infection (Hegazy et al., 2010); other data indicate that IFNγ – the proto-typical Th1-
inducing cytokine – is also important for Th2 cell formation (Bocek, Foucras, and Paul,
2004). The environment in which the virus grows changes with time, so it is plausible that
CD4 differentiation is flexible and varies according to the local abundances of cytokines and
antigen that occur throughout the response.
Memory T cells are a first line of defense against re-infection
CD4 T cell memory is typically seen after infection or vaccination and, where examined, it
is long-lived. There are some examples of memory waning over time (Homann, Teyton, and
Oldstone, 2001), but other data show fairly stable levels over time (Hammarlund et al.,
2003; Harrington et al., 2002; Varga and Welsh, 1998; Whitmire et al., 1998). Evidence
from studies utilizing “marked effector cells” indicate that memory T cells are derived from
antigen-experienced effector cells in a linear differentiation process from naïve to effector to
memory cell (Harrington et al., 2008; Hu et al., 2001; Jacob and Baltimore, 1999;
Opferman, Ober, and Ashton-Rickardt, 1999). These studies used transgenic T cells that
contain an inactive marker, which recombines when the T cells are stimulated by antigen;
those T cells and all of their progeny can be identified by flow cytometry. Several studies
using this approach show that memory cells that form after infection are marked, indicating
a direct relationship between the effector cells and memory cells.
Memory precursors can be identified early on based on their expression of IL-7R and their
ability to bind tetramers (Kaech et al., 2003; Kondrack et al., 2003; Lenz et al., 2004; Li,
Huston, and Swain, 2003; Seddon, Tomlinson, and Zamoyska, 2003). During the initial
response memory precursors emerge. Virus-specific CD4+ T cells down-regulate IL-7R, but
there are cells that re-express IL-7R (Kaech et al., 2003; Kondrack et al., 2003; Lenz et al.,
2004; Li, Huston, and Swain, 2003; Seddon, Tomlinson, and Zamoyska, 2003) and down-
regulate KLRG1 (Hand, Morre, and Kaech, 2007; Joshi et al., 2007). After the infection is
resolved, the swollen number of effector cells is no longer needed and it is energetically
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expensive to sustain such a vast population of cells. Therefore, most of the cells (~90%) are
purged during the contraction phase and the survivors have the characteristics of memory
cells (described below). The other effector cells undergo cell death and the IL-7R+
population accumulates (or at least doesn’t die); over time, only IL-7R+ cells remain and
they behave like memory cells. The increased proportion of IL-7R+ cells that is seen during
the contraction phase could either be the result of deletion of IL-7R− cells, an intrinsic
change in cells from IL-7R− to IL-7R+, or a combination of IL-7R+ cell division and
accumulation along with the loss of IL-7R− cells; there is evidence consistent with all of
these scenarios. The purging process is enigmatic because cell selection and survival into the
memory phase occurs in the apparent absence of virus replication and inflammation. Most
evidence indicates that the virus-specific T cells undergo caspase-dependent apoptosis, and
the surviving T cells tend to express increased amounts of Bcl2, Bcl-xL, and Bcl6 (Grayson
et al., 2006; Grayson et al., 2000; Homann, Teyton, and Oldstone, 2001; Pipkin et al., 2010)
compared to effector cells.
Once established, CD4 T cell memory does not require antigen (Swain, Hu, and Huston,
1999) but depends upon cytokines derived from stromal cells. Antiviral CD4+ T cells use
IL-7 and, to a lower extent, IL-15 for homeostatic maintenance (Jaleco et al., 2003; Lenz et
al., 2004; Purton et al., 2007). In the absence of these cytokines, virus-specific CD4+ T cells
decline in number; conversely, their number can be increased above normal when
recombinant versions of these cytokines are given to mice (Boyman et al., 2008; Boyman,
Surh, and Sprent, 2006; Cho et al., 2007; Rubinstein et al., 2006).
Quiescent memory T cells are responsible for the expedited immunologic protection seen
after immunization. As described below, naïve and memory cells differ dramatically in
frequency, sensitivity to antigen, cytokine output, and location, which explain why memory
cells confer enhanced immunity compared to naïve cells.
Frequency—Immune mice mount recall responses that are detectable sooner than primary
responses. The accelerated appearance of the recall response can be explained by the
differences in frequency between virus-specific naïve cells (~100 per mouse) that are well
below detection by standard assays versus memory cells that can be 500- 1000-fold more
abundant. Upon challenge, the naïve cells need to undergo far more rounds of cell division
and accumulation before they are detected; memory T cells only need to go through a few
rounds; hence, memory responses appear sooner. Most analyses of memory T cells have
been done in immune mice, and the results from these mice were compared to those from
naive mice. However, there are numerous differences between these two groups of mice,
including the virus-specific T cell frequency and the presence of virus-specific antibody and
CTL that affect antigen load and APC function. To investigate whether the differentiation
changes that occur during the transition of effector cells into memory cells result in quicker
cell division rates, LCMV-specific T cells were transferred into naïve mice that were
subsequently infected (Whitmire, Eam, and Whitton, 2008) and were allowed to
differentiate into memory T cells. These memory T cells were isolated, mixed with naïve
cells, labeled with CFSE, and adoptively transferred into the same naïve host. Upon
infection, the two donor populations were identified by flow cytometry. The data indicate
that when compared in the same host and at similar frequencies, memory T cells and naïve T
cells begin cell-division at around the same time (Whitmire, Eam, and Whitton, 2008).
The recall response mediated by memory T cells is typically more robust than the primary
response. Once naïve and memory T cells begin dividing, the effector cells derived from the
memory T cells accumulate more efficiently than the primary effector cells (MacLeod et al.,
2008; Whitmire, Eam, and Whitton, 2008). As a result, there is a rapid rise in the number of
secondary effectors. The rapid accumulation of memory cells compared to their naïve
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counterparts may relate to the efficiency with which memory cells produce cytokines (IFNγ,
IL-2) that increase cell division or prevent apoptosis; however, the accumulation could be
the result of other epigenetic changes (intrinsically elevated Bcl2 levels). There may also be
refinement of virus-specific cells so that only the best responders are selected to survive into
the memory phase; these cells may have slight alterations in TCR structure that make them
better able to respond compared to the mixed population of naïve T cells that react to the
same epitope (Williams, Ravkov, and Bevan, 2008). Other genomic changes may be at play
in enhancing the responsiveness of memory cells following infection, including their
increased frequency in peripheral tissues (Klonowski et al., 2004; Lefrancois, 2006).
Sensitivity to antigen—Compared to naïve cells, memory T cells are 50- 500-fold more
sensitive to antigen (Slifka and Whitton, 2001; Whitmire, Benning, and Whitton, 2006;
Williams, Ravkov, and Bevan, 2008). The improvement in sensitivity to low quantities of
antigen occurs during the expansion phase and carries on into memory. The molecular
mechanisms that permit greater sensitivity have not been worked out: there may be
differences in TCR abundance, preformed signaling components associated with the TCR,
or increased levels of accessory molecules that improve T cell association with target cells.
For example, memory cells express pre-formed costimulatory molecules that can
immediately be secreted to the surface of cells to engage APCs (Koguchi et al., 2007).
Effector functions—A major difference between memory T cells and naïve T cells is
their ability to rapidly make cytokine (Liu, Whitton, and Slifka, 2004; Rogers, Dubey, and
Swain, 2000). When exposed to infection, memory T cells secrete IFNγ within minutes. We
utilized an in-vivo method to detect T cells that make IFNγ after infection (Foster et al.,
2007; Liu and Whitton, 2005; Whitmire, Eam, and Whitton, 2008). The method involves
infecting mice and then treating them with Brefeldin-A to force reactive T cells to sequester
cytokine intracellularly. Splenocytes are harvested and immediately surface stained to
identify virus-specific cells and stained for intracellular levels of IFNγ. Using this assay, we
compared naïve and memory T cells in the same host and found that memory cells respond
to infection by producing IFNγ by 6– 12 hours after infection; naïve T cells in the same
conditions did not make detectable levels of IFNγ. (Whitmire, Eam, and Whitton, 2008)
These data show that memory cells are geared to respond quickly to infection by producing
antiviral cytokine. The IFNγ locus is epigenetically modified in memory cells compared to
naïve cells (Kersh et al., 2006; Northrop et al., 2006); the histones at this locus are
demethylated, thus making the local heterochromatin open and accessible to transcription
factors. These data resemble what is found for memory CD8+ T cells: virus-specific CD8+
T cells in immune mice kill target cells within minutes (Barber, Wherry, and Ahmed, 2003;
Yates et al., 2007). Hence, a quiescent population of CD8+ memory cells can defend very
quickly and during the same periods usually associated only with the innate immune system
– thus, memory T cells exert their effects long before their accumulation appears.
Cytokine patterns—As responding T cells differentiate, they increase their ability to
produce IFNγ, TNF, and IL-2. It is not clear why there is a difference in kinetics between
IFNγ production and IL-2 secretion, but it may relate to the antiviral activity of IFNγ, which
is needed immediately. The ability to make these cytokines appears to be sequential: early
on many cells make IFNγ but not IL-2, but by the peak of the response, most effector cells
make all three cytokines. The early production of IFNγ and TNF serves to diminish virus
infection and activate macrophages and dendritic cells. IFNγ production by responding T
cells may be directly linked to their enhanced expansion (see below). Early production of
IL-2 could be detrimental to expanding effector cells if its impact of on NK cells or Treg
cells is greater than that on T cells. The delayed production of IL-2, a growth and survival
factor of T cells, may correspond with the transition of effector cells into the memory phase:
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IL-2 given during the contraction protects antiviral CD8+ and CD4+ T cells from apoptosis
and increases memory. The expedited production of IL-2 by memory T cells may play a role
in accelerating their accumulation once cell-division commences.
Interferons simultaneously suppress virus replication in target cells and stimulate antiviral
T cells that ward off further infection
Numerous viruses encode proteins that either prevent the induction of IFN or block
signaling cascades that result from IFN signals. RNA viruses are usually capped to prevent
recognition by PRRs and induction of interferon; additionally, members of the picornavirus
family (CVB, poliovirus, HAV) prevent encode proteins that block parts of the interferon
induction process or block interferon-receptor signals. Other RNA viruses, such as members
of the flavivirus produce non-structural proteins that prevent type1 IFN induction as well as
IFN signaling. Vaccinia virus encodes decoy receptors for both type 1 and type 2
interferons. The elaborate mechanisms that viruses use to inhibit IFN highlight the key role
of these pathways in immune defense.
Numerous pathways are involved in the inflammatory response and result in signals that act
directly on T cells. For example, PRRs (NLR, TLR) are involved in initiating the response
and lead to IFNαβ production by the infected cell, which may act directly on responding T
cells and impact their functions or accumulation. Also, early IFNγ production by NK cells
and responding T cells acts upon the IFNγR, which leads to JAK1/2 recruitment followed by
STAT1 phosphorylation by JAK1. The STAT1-PO4 forms homodimers that travel to the
nucleus and bind to promoter elements called Gamma Activated Sequences, which are near
hundreds of genes that are upregulated as a consequence of IFNγR signaling. IFN functions
immediately during infection, but the long-term consequence of IFN signaling is the
stimulation large numbers of effector and memory T cells. The expansion of the CD4+ T
cell population depends on several critical pathways, which likely influences the timing and
magnitude of T cell responses. Sequential waves of interferons and costimulatory molecules
are expressed after infection, and these interactions may result in distinct effects on T cell
differentiation that varies with time (Bertram, Lau, and Watts, 2002).
We have shown that T cells need direct IFNγ signals to fully expand, and they compete for
this cytokine as they differentiate into effectors and memory cells (Whitmire et al., 2008;
Whitmire, Benning, and Whitton, 2005; Whitmire et al., 2007; Whitmire, Tan, and Whitton,
2005). The receptor for IFNγ, CD119, is expressed ubiquitously; however, the surface level
of expression increases selectively on responding virus-specific T cells, consistent with the
notion that IFN signals directly into T cells and enhances their ability to respond. To better
understand the role of direct IFN signals in virus-specific T cell differentiation, we
compared in the same host T cells that were genetically deficient in γR-expression with T
cells that express γR (Whitmire et al., 2008; Whitmire, Benning, and Whitton, 2005;
Whitmire et al., 2007; Whitmire, Tan, and Whitton, 2005). Under these conditions, the T
cells – which are identical in their specificity – were transferred into the same WT host,
where they were exposed to the same antigen load and duration. We found that after
infection, γR− T cells expanded to lower numbers compared to the T cells that expressed
γR, despite being present at equal numbers before infection. Similar results were seen when
comparing γR+ versus γR− TCR-transgenic T cells or when endogenous virus-specific T
cells from γR+ or γR− mice were compared in the same host. Our findings closely parallel
those reported for IFNαβ signals, where T cells that are sensitive to IFNαβ expand in
number more vigorously than do T cells that are αβR-deficient (Havenar-Daughton,
Kolumam, and Murali-Krishna, 2006; Kolumam et al., 2005), and we confirmed this
observation (unpublished data). The findings with αβR-deficient T cells are consistent with
the evidence that TLRs enhance T cell memory; TLR signals alter APC antigen presentation
capacity and stimulate IFNαβ production from them, which acts directly on responding T
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cells. Thus, IFNs act on target cells to diminish virus replication and act on responding
virus-specific T cells to augment their accumulation.
Some reports indicate that IFNs are detrimental to T cell memory formation or that there is
no impact on memory cell formation (Badovinac, Porter, and Harty, 2004; Dalton et al.,
2000; Haring and Harty, 2006; Tewari, Nakayama, and Suresh, 2007). The varied
conclusions likely stem from differences in the methods and model systems. For example,
analyses comparing T cell memory in separate WT and IFN-deficient mice is problematic
when the pathogen load and duration differs. A similar concern holds when a large
proportion of APCs or other cell-types (T-reg cells, etc) are IFNγR-deficient, as in a bone-
marrow chimera. It is important to consider that the role of IFN likely varies depending on
the pathogen: virus infections typically stimulate large amounts of IFN, but bacterial
infections stimulate an entirely different set of cytokines: other cytokine networks may
dominate in stimulating T cell responses after bacterial infection. The effect of direct IFN
signals appears after day 4 post-LCMV infection, when the cells are accumulating
exponentially; the role of IFN may not be as apparent in infections or vaccinations where the
stimulus does not drive extensive cell division and accumulation. Hence, weak stimuli that
drive only a few fold changes in cell number may not appear to be impacted by IFNs.
During a response, restrictive numbers of APC force T cells to compete for antigen; under
increasing amounts of competition, smaller and smaller proportions of the cells undergo cell
division. We have shown, by varying the frequency of naïve virus-specific TCR-transgenic
T cells before infection, that an overabundance of identical T cells is detrimental to antiviral
T cell memory. Virus-specific CD8+ T cells and other CD4+ T cell responses show a similar
pattern (Blair and Lefrancois, 2007; Foulds and Shen, 2006; Hataye et al., 2006; Kedl et al.,
2000; Sarkar et al., 2007; Srinivasan, Foley, and McSorley, 2004; Troy and Shen, 2003;
Whitmire et al., 2008; Willis, Kappler, and Marrack, 2006). The negative impact on T cell
memory suggests that T cell differentiation may be linked to cell division. As antigen
becomes limiting and T cell number increases, the competition for antigen becomes severe
with time. T cell production of IFNγ is tightly controlled by contact with antigen (Slifka,
Rodriguez, and Whitton, 1999), so the effect of constrained amounts of antigen impacts
virus-specific T cell production of IFNγ, thus limiting direct IFNγ signaling into T cells.
We propose a link between T cells that most efficiently elaborate IFNγ secretion and receive
IFNγR signals and their competitive fitness to out-expand other T cells and go on to
differentiate into memory T cells following acute virus infection (Figure 3). IFNs in
particular select cells into the memory pool: competition between cells for limiting amounts
of IFN is a deciding factor in determining which cells survive initial expansion and go on to
populate the memory pool. It is not yet clear whether the effect of IFNγR signals merely
increases the abundance of cells with the potential to differentiate into memory cells or
directly stimulates the memory program. However, it is noteworthy that in the absence of
direct γR signals, there is a precipitous loss of T cell memory compared to identical cells
that express γR. In other words, the initial difference between the two populations at the
peak of the response exaggerates as the cells differentiate into the memory phase, suggesting
that there is a direct connection between these signals and the memory program. Further
studies are required to delineate how direct IFN signals impact memory cell formation and if
the long-term effects are set early on or actively deployed during the contraction phase.
T cells also appear to compete for limiting amounts of IL-7, IL-15, and IL-2: when these
cytokines are delivered as complexes to mice so that they are overabundant across several
days, antigen-specific T cells are driven to tremendous number (Boyman et al., 2006;
Boyman et al., 2008; Finkelman et al., 1993; Kamimura and Bevan, 2007; Kamimura et al.,
2006; Purton, Martin, and Surh, 2008; Rubinstein et al., 2006). Conversely, when T cells are
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starved of these cytokines, there are severe reductions in the initial expansion and memory
levels. It is plausible that these cytokines factor into the memory selection process and
support translational efforts to use cytokine-mediated immunotherapy to increase the
abundance of vaccine-induced memory T cells.
There are gaps in our understanding of how other pro-inflammatory pathways affect T cell
memory formation. Some pathways act directly on responding T cells, others function
indirectly through APCs, and some (MyD88, IFNαβ, IFNγ) act on both. NLRs sense
bacterial and some DNA or RNA virus infections (Allen et al., 2009; Ichinohe et al., 2009;
Kuenzel et al., 2010; Lamkanfi and Kanneganti, 2010; Neerincx et al., 2010). NLRs induce
IL-1β production, which signals directly into T cells to enhance their expansion (Ben-Sasson
et al., 2009). Consistent with this notion, IL-1R-deficient mice show deficits in lung CD4+ T
cell responses following influenza infection (Schmitz et al., 2005). IL-12 and IL-18 are
made by activated dendritic cells after virus infection; T cells express receptors for these
cytokines and their differentiation into Th1 cells is impacted by these signals (Srinivasan et
al., 2007) and may affect the expansion of CD4+ T cells and their differentiation into
memory cells (Boelen et al., 2002; Haring and Harty, 2009; Pien et al., 2000; Srinivasan et
al., 2007; Tough, Zhang, and Sprent, 2001). Type-III interferons (IFN-λ) are produced
during some virus infections and are particularly abundant at skin and mucosal sites. IFN-λ
is stimulated by some of the pathways that induce IFNαβ; the receptor for IFN-λ is
IL-28Rαβ and is expressed on a limited number of cells, including T cells (Donnelly and
Kotenko, 2010). IFN-λ signaling into non-T cells diminishes virus replication in target cells
and results in an IFNαβ burst. The effect of IFN-λ signaling into antiviral T cells and their
ability to form memory cells remains to be investigated. From the standpoint of improving
vaccines against viruses, it would be interesting to learn whether the quality or number of
memory cells differs when they differentiate with IFNγ signals versus IL-1β, IFNαβ, IFN-λ,
IL-12, or IL-18. DNA viruses and RNA viruses differ in the kinds of innate pathways that
are stimulated, and there may be consequent effects on virus-specific T cell memory.
TLR ligands also act on T cells to augment their responses (Marsland et al., 2007). MyD88
conveys signals emanating from TLRs that induce IFN within target cells, but there may be
additional functions for this molecule. Intriguing data show that MyD88 signals within T
cells influence their accumulation after viral infections (Rahman et al., 2008; Zhao et al.,
2009; Zhou et al., 2009). Thus, additional MyD88 functions may overlap with MyD88-
mediated induction of IFN signaling to enhance antiviral T cell responses. T cell
differentiation is likely determined by a variety of signals, including TCR strength and
duration, IFN and other combinations of pro-inflammatory cytokines, and TLR signaling
(Nembrini et al., 2006).
Discussion
Antiviral CD4+ T cell responses begin from a small number of cells that undergo
tremendous rates of cell division and accumulate under the positive influence of
inflammatory cytokines. These early signals enhance their number and further their
differentiation into memory cells. Once set, CD4 memory is maintained by homeostatic
cytokines and by B cells through unknown mechanisms. Th1 memory cells sustain antiviral
CD8 T cell responses and are involved in CD8+ T cell recruitment to peripheral sites; other
lineages of antiviral CD4+ T cells can be found after infection, but their longevity and
protective role during recall responses need to be studied.
Most studies have examined the influence of innate immune defense on developing T cells,
but in an immune individual, the adaptive response occurs concurrently and possibly before
innate defenses. How do cytokine-secreting memory T cells affect infected target cells, APC
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function, and NK cell activity? How do these signals impact ISG functions within infected
target cells, given that some proteins (eg, MyD88) may have multiple functions?
Conversely, there is evidence that innate immunity influences effective recall responses: in
the absence of PKR – a cytoplasmic sensor of viral RNA that stimulates IFN responses –
existent memory CD8+ T cells did not effectively eliminate a challenge virus infection
(Nakayama et al., 2010). Thus, innate detection of infection and the positive effects of
inflammatory cytokines on established T cell memory is an important area for future
investigation, as it relates to how best to boost immunity with vaccination.
The role of IFNs, costimulatory molecules, and pro-inflammatory cytokines during chronic
virus infection could be very different from that seen during acute infection. The immune
system is hyper-activated during HIV infection, such continuous stimulation may induce an
endogenous program that downregulates adaptive immunity under these circumstances.
During chronic virus infection, virus-specific T cells are either deleted or become
dysfunctional over time (Brooks et al., 2005; Fuller et al., 2005; Fuller et al., 2004; Fuller
and Zajac, 2003; Mothe et al., 2007; Zajac et al., 1998a; Zajac et al., 1998b). Antiviral
CD4+ T cells become non-functional like CD8+ T cells. The molecular mechanisms
underlying these effects are still being uncovered; current analyses show PD1L-PD1 (Barber
et al., 2006; Bengsch et al., 2010; Blackburn et al., 2009; Freeman et al., 2006; Grosso et al.,
2009; Wherry et al., 2007), CD27–CD70 (van Gisbergen et al., 2009), CTLA4-B7, Lag3
(Bengsch et al., 2010; Blackburn et al., 2009), and IL10-IL10R (Brooks et al., 2008; Brooks
et al., 2006; Ejrnaes et al., 2006) interactions inhibit reactive cells during chronic infection
in mice and in people. During chronic virus infection, reactive T cells may produce IFNγ –
possibly lower amounts than seen during acute infection – and the expression of this
cytokine might have inhibitory effects during chronic infection: IFNγ induces PD1L on
APCs (Muhlbauer et al., 2006; Schreiner et al., 2004), and IFNγ acts on Treg cells to
increase their inhibitory activity. Data in other models indicate that IFNγ signals into non-T
cells inhibit memory T cell formation (Sercan et al., 2006; Sercan et al., 2010). While the
amount and duration of antigen can enhance CD4 T cell responses following acute infection,
recent evidence shows that extensive persistence of large amounts of antigen can be
detrimental to CD4+ T cell responses (Han et al., 2010), and CD4+ T cells that are removed
from such an environment can recover their ability to produce cytokine. Treating chronically
infected mice with ribavirin results in a reduction in virus load, and exhausted CD4+ T cells
recover some of their functions (Brooks, McGavern, and Oldstone, 2006). Thus, chronic
virus infection may diminish CD4+ T cells by induction of immunosuppressive cytokines
and inhibitory cell-surface molecules, or by simply over-stimulating them. Future studies
need to clarify the roles of type 1 and type 2 IFN on antiviral T cell responses throughout
chronic virus infection. Interestingly, persistent LCMV infection of mice does not result in
persistently elevated levels of IFNαβ, suggesting that there are other mechanisms at play that
diminish innate immune responses – perhaps the inhibited production of IFNαβ is related to
the development of exhausted T cells.
The magnitude of the primary and recall CD4+ T cell response is governed by antigen load
and pro-inflammatory cytokines, and the two factors are linked: the antigen load influences
how much IFNγ is made by responding T cells and the extent to which they receive direct
IFNγ signals. The principal mechanism for priming antiviral CD4+ T cells is through
endocytic processes that take-up extracellular protein, degrade it, and load the resulting
peptides onto MHCII molecules. However, other mechanisms, including macroautophagy,
result in the presentation of peptides from cytosolic proteins (Deretic, 2009; Gannage and
Munz, 2009; Lee and Iwasaki, 2008; Munz, 2006; Munz, 2007). CD4+ T cell responses
form against HSV and EBV (nuclear antigen 1 EBNA1) proteins that are in the cytoplasm of
MHCII+ cells. Certain proteins that have escaped ubiquitin-mediated proteasomal
degradation can be captured by autophagosomes and transported to lysosomes. These tend to
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be long-lived proteins and also ones that form large aggregates, which become encapsulated
in autophagosomes that fuse with lysosomes, where the proteins are degraded and loaded
onto resident MHCII molecules. In addition to macroautophagy, chaperone-mediated
autophagy – the active heat-shock protein mediated transport of proteins directly into the
lysosome – results in proteolytic degradation of proteins into peptides that bind to MHCII
molecules. Virus proteins aggregate to form structures that efficiently package their
genomes, which may induce the autophagosomal process and lead to peptides that are
recognized by CD4+ T cells. The extent to which macroautophagy contributes to the overall
CD4+ T cell response after virus infection remains to be quantified and compared to the
well-established exogenous pathway. Type 1 and Type 2 interferons increase the amount of
autophagy within cells, which may enhance the amount of antigen is presented to CD4+ T
cells and affect the magnitude of the response. There may also be differences in how
proteins are degraded in the late endosome/lysosome pathway versus the autophagosome/
lysosome pathway, potentially determining the populations of virus-specific CD4+ T cells
that respond. Lysosomes that have fused with autophagosomes may contain different sets of
molecules compared to lysosomes that fuse with phagosomes; the co-expression of these
other molecules with MHCII molecules on the surface of cells might also influence the
developing CD4+ T cell response. Many viruses encode proteins that prevent MHC
presentation; this may impact CD4+ T cell responses that depend upon autophagosome-
mediated antigen presentation in the same infected cell but not affect CD4+ T cells that
recognize antigen produced in the classical phagocytic process or receptor-mediated uptake
in non-infected cells. It is unclear what proportion of CD4+ T cells respond to material
derived from extracellular protein versus macroautophagy, and how these pathways differ in
T cell-dependent protection.
The genomics of antiviral immunity
Nearly all analyses of immune response to vaccination or infection are done in highly inbred
mouse models. Pre-clinical studies to evaluate vaccines typically begin with studies in
standard inbred mouse models. General response patterns in mice will mimic those in
people, but there are exceptions, which need to be studied. Mouse models are useful,
because many tools are available to quantify immune responses, which is essential for
understanding the underlying processes involved in resolving infection and establishing T
cell memory. However, there are several problems with existing mouse models: much of the
immune response is dominated by a few genes, different inbred mouse strains have lost
some of these genes, and mice vary in their expression of the these genes, which may not
match with normal expression patterns. Additionally, many inferences about certain
pathways are based on data from gene-ablated mice – such experimental approaches are
straightforward and easy to interpret, but rarely do people have absolute deficiencies in
those particular genes. Normal individuals vary in alleles of genes and in the amount of
expression of those genes, and they differ in non-coding regions of the genome. Critical
variation beyond allelic variances at the MHC locus includes differences in intrinsic
antiviral pathways and PRRs, including the induction of interferons that amplify differences
in subsequent T cell responses. All of these differences with intact genes impact phenotypes
seen in people – such natural variation is not replicated in inbred strains of mice. A robust
outbred mouse model that factors in the natural variations in components of these networks
may better predict which pathways are critical for immunity (Churchill et al., 2004; Yalcin
et al., 2010). The quantitative analysis of immune responses following infection or
vaccination in outbred populations of mice followed by quantitative associations with
certain genetic loci associated with inflammation will play a key role in the future for
dissecting how to best develop protective immune responses with vaccines.
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• Memory T cells are a first line of defense against re-infection.
• CD4+ T cells directly suppress infection and enhance CD8+ T cell & B cell
responses.
• T cell differentiation is driven by antigen, interferons, and other pro-
inflammatory cytokines.
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Figure 1. The central role of virus-specific CD4 T cells in immune defense
Antiviral CD4+ T cells affect multiple wings of the immune system to protect against
infection. CD4+ T cells interact directly with antigen presenting cells to enhance their ability
to present viral antigen to T cells. They engage B cells and direct their differentiation into
memory B cells and plasma cells and affect the kind of antibody that is made. CD4+ T cells
can directly suppress virus infection in MHCII+ target cells. CD4+ T cells are essential for
the induction of antiviral CD8+ T cell responses to many infections and enhance the
protective recall response of memory CD8+ T cells.
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Figure 2. The T cell response following acute LCMV infection in mice
The T cell response following acute LCMV infection provides a well-defined model to study
how CD4+ T cells, CD8+ T cells, and B cells responses develop. The graph shows the
dramatic increase in number of virus-specific T cells after infection and the establishment of
elevated numbers of memory T cells. The innate immune response begins immediately after
infection and affects the subsequent T cell response. Responding T cells produce interferon-
gamma and express other molecules that impact their expansion in number and
differentiation into memory cells. The essential patterns are shown for a robust acute
infection, but other infections show smaller or delayed responses that are related to
differences in the magnitude or duration of infection and variations in the inflammatory
environment.
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Figure 3. Selection of the fittest: virus-specific CD4+ T cells compete for antigen and cytokines,
selecting and enriching for high quality memory cells
Antiviral CD4+ T cells respond to antigen and inflammation by undergoing cell-division,
which can be incredibly rapid. As they accumulate in number, effector T cells begin to
compete for access to antigen, which constrains cell-division for cells that weakly interact
with antigen. In addition, the most vigorously responding T cells produce IFNγ and receive
direct IFNγ signals; the best responders receive the greatest amount of IFNγ signaling and
continue to accumulate. IFNγ signals also enhance memory cell formation. It is unclear if
direct IFNγ signals activate a program of memory cell differentiation or increase the number
of memory cell precursors that have the potential to survive.
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